Results 211 to 220 of about 415,778 (252)
Clinical risk factors associated with poor prognosis in gastric cancer patients with peritoneal metastasis. [PDF]
Su A, Guo R, Wu C.
europepmc +1 more source
ABSTRACT Introduction Sarcomatoid urothelial carcinoma is a rare, highly aggressive bladder cancer subtype. We report the first case of abdominal wall implantation of sarcomatoid urothelial carcinoma after bladder perforation during transurethral resection of a bladder tumor, followed by recurrence at the open repair site requiring further resection ...
Tomoki Kimura +8 more
wiley +1 more source
Conversion surgery after immunotherapy and chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology: A retrospective cohort study. [PDF]
Liang H +10 more
europepmc +1 more source
Our graphical abstract summarizes a novel immunosuppressive axis in HCC whereby tumor cell‐derived SCF recruits and activates mast cells, leading to CCL17 secretion and subsequent recruitment of CCR4+ regulatory T cells. This cascade suppresses CD8+ T cell‐mediated antitumor immunity and promotes resistance to anti‐PD‐1 therapy.
Shuai Yang, Chuang Yang
wiley +1 more source
Spectral CT iodine quantification for peritoneal metastasis burden and resectability prediction in ovarian cancer: a retrospective cohort study. [PDF]
Liu Y, Wu X, Deng H, Lin Y, Lin M.
europepmc +1 more source
Efferocytosis is a key process for macrophages to clear apoptotic cells, which undergoes the “ Find Me” chemotaxis signal stage, the “eat me” phagocytosis recognition stage and the “digest me” digestion stage in turn. During the aforementioned three stages, various signaling molecules released by apoptotic cells can promote the phenotypic polarization ...
Qiuping Chen +3 more
wiley +1 more source
Role of diagnostic laparoscopy in preoperative staging and resectability assessment for cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in peritoneal metastasis. [PDF]
Kazanowski M +8 more
europepmc +1 more source
Liquid Biopsy: Past, Present, and Future
Liquid biopsy has expanded from cancer genotyping to a broader strategy for probing both oncologic and nononcologic conditions through circulating analytes and multilayer molecular readouts. This review traces the field's past, present, and future—summarizing where liquid biopsy is most actionable today, why performance varies across contexts, and ...
Jiachen Liu +8 more
wiley +1 more source

